Defeat Cancer by Detecting it Early
EarlyDiagnostics (EarlyDx) is devoted to providing accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine.
Big Data for Better Diagnosis
We have developed a blood test, CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. In addition, we developed a One-Stop Shop bioinformatics solution, EarlyDx-Cloud, to help many diagnostic companies offer liquid biopsy tests for cancer detection, therapy selection, and treatment monitoring.
how it works
The Technology behind Cancer Detection
Our Experts Are Waiting For You
We bring the right people together to challenge established thinking and drive transformation.
EarlyDx announced appointment of Guanghui Hu as co-CEO.
EarlyDx published cfTrack: Non-invasive monitoring of cancer MRD, Recurrence, and Evolution in Clinical Cancer Research.
EarlyDx Awarded an NIH SBIR Phase I Contract for Cloud Platform Development.